Skip to main content
Fig. 6 | BMC Pulmonary Medicine

Fig. 6

From: Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study

Fig. 6

Fitted survival probabilities of first-line and second-line antifibrotic therapy. The cumulative survival probabilities from initiation of second-line AFT in patients with Switch-IPF and survival probabilities of first-line AFT in patients with Non-Switch-IPF (A). Diagram showing the multistate model used for modeling the impact of “switching antifibrotic therapy” on survival in patients with IPF (B). Fitted survival probability curves based on transition intensities from state 1 to state 3 (i.e., transitioning to death without switching antifibrotics) and state 2 to 3 (i.e., transitioning to death after switching antifibrotics) in the unadjusted multistate model (C)

Back to article page